Haleos Labs Ltd

NSE: HALEOSLABS · BSE: 540679 · Pharmaceuticals & Biotechnology · 24 announcements

Share price: ₹1,584.70
Market cap: ₹479.1 Cr
Revenue (annual): ₹333.8 Cr
Net profit (annual): ₹17.31 Cr
P/E (TTM): 30.3×Sector 47.3×
Promoter holding: 72.11%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Annual General Meeting 5 Other Announcement 4 Management Change 4 Financial Results 3 Dividend 2 Board Meeting Date 2 Promoter Reclassification 1 Credit Rating 1 Business Update 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

8 Apr 2026 11:50 IST BSE

Promoter Reclassification

Haleos Labs Promoter Reclassification

Haleos Labs Ltd has received annual declarations from erstwhile promoters Mr. Suresh Babu Potluri and Mr. Hari Kishore Potluri. They confirm continued compliance with SEBI's reclassification norms, holding less than 10% voting rights and exercising no control over the company. This maintains their status within the public shareholding category.

Read the filing ↗